N P Konovalova Selected Research

N P Konovalova Research Topics

9	Neoplasms (Cancer) 07/2017 - 01/2000
4	Leukemia P388 07/2017 - 01/2003
4	Leukemia 01/2013 - 01/2000
4	Experimental Melanoma 01/2006 - 11/2002
3	Neoplasm Metastasis (Metastasis) 01/2006 - 01/2000
1	Necrosis 04/2009
1	Leukemia L1210 11/2002
1	Colorectal Neoplasms (Colorectal Cancer) 01/2000

5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2017 - 01/2003
3	Hydroxamic Acids (Hydroxamic Acid)IBA 07/2017 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 07/2017 - 11/2002
3	Cytostatic AgentsIBA 02/2003 - 11/2002
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2003 - 01/2000
2	Pharmaceutical PreparationsIBA 07/2017 - 11/2002
2	Daunorubicin (Cerubidine)FDA LinkGeneric 07/2017 - 01/2000
2	Proteins (Proteins, Gene)FDA Link 04/2009 - 11/2002
2	Nitric Oxide DonorsIBA 04/2009 - 02/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2003 - 01/2000
2	DNA (Deoxyribonucleic Acid)IBA 11/2002 - 12/2001
2	AK 2123IBA 12/2001 - 01/2000
1	Vincristine (Oncovin)FDA LinkGeneric 07/2017
1	OxidesIBA 01/2013
1	EnzymesIBA 01/2013
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2013
1	Adenosine Triphosphatases (ATPase)IBA 08/2008
1	IonsIBA 01/2006
1	Immunologic Factors (Immunomodulators)IBA 01/2003
1	AntioxidantsIBA 01/2003
1	Biological ProductsIBA 01/2003
1	lonidamineIBA 01/2003
1	Ecdysterone (20 Hydroxyecdysone)IBA 11/2002
1	Antineoplastic Agents (Antineoplastics)IBA 11/2002
1	Carrier Proteins (Binding Protein)IBA 12/2001
1	TriazolesIBA 01/2000
1	ruboxylIBA 01/2000
1	nitroxylIBA 01/2000
1	Fluorouracil (Carac)FDA LinkGeneric 01/2000
1	Etoposide (VP 16)FDA LinkGeneric 01/2000